Lombard Odier Asset Management (Europe) Ltd
Position in CYTK — Cytokinetics Inc
CIK 1535784
LONDON, X0
Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Derivatives in CYTK
reported options exposure · as of Jun 30, 2026CallValue
$13,494,096
CallShares
158,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lombard Odier Asset Management (Europe) Ltd holds $3,715,051 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,958 | $3,715,051 |
All Filings in CYTK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,494,096 | 158,400 | Call | Other | 2026-08-14 | |
| 2026-03-31 | $6,749,184 | 102,400 | Call | Other | 2026-05-15 | |
| 2025-12-31 | $5,655,060 | 89,000 | Call | Other | 2026-02-17 | |
| 2025-06-30 | $1,526,448 | 46,200 | Call | Other | 2025-08-14 | |
| 2025-03-31 | $1,856,778 | 46,200 | Call | Other | 2025-05-15 | |
| 2024-09-30 | $6,431,040 | 121,800 | Call | Other | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||